Updated EAU Guidelines for Clear Cell Renal Cancer Patients Who Fail VEGF Targeted Therapy

Abstract

Metastatic clear cell renal cell carcinoma still has a poor outcome despite the introduction of targeted therapy. New recommendations for patients who have failed one line or more of previous VEGF targeted therapy / failed VEGF targeted therapy and imune checkpoint inhibitors.

Keywords

• carcinoma
• trial